A translational pediatric cancer grant supporting development of promising therapies for blood cancers and solid tumors. Two-step funding mechanism totaling up to $300,000 over two to three years.
Eligibility Criteria:
-
Research must be original and focused on pediatric liquid or solid cancers.
-
Applicant must hold an MD, PhD, MD/PhD (or equivalent); postdoctoral researchers are eligible.
-
Institution must be U.S.-based and nonprofit or academic.
Funding Details:
-
Tier 1: $100,000 for 1 year (translational pediatric oncology research).
-
Tier 2: $100,000–$200,000 for 1–2 additional years (for successful Tier 1 recipients).
Deadline:
-
Letter of Intent: July 3, 2026
-
Full Proposal (invited only): October 16, 2026
Where to go for further information: